Koronare Herzkrankheit (allg. Teil 4)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88]
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie

  1. ↑ The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 29(8):1057-71 (2008) PMID 18346962
  2. ↑ Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Eur Heart J 29(3):299-314 (2008) PMID 18245118
  3. ↑ Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 29(2):277-8 (2008) PMID 17971402
  4. ↑ Use of the electrocardiogram in optimizing reperfusion for ST-elevation myocardial infarction: a new role for an old tool? Eur Heart J 28(24):2957-9 (2007) PMID 18006542
  5. ↑ Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28(22):2706-13 (2007) PMID 17901079
  6. ↑ Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J 28(17):2077-86 (2007) PMID 17600038
  7. ↑ Link between erythropoietin release and mobilization of endothelial progenitor cells in acute myocardial infarction. Eur Heart J 28(15):1785-6 (2007) PMID 17606470
  8. ↑ Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28(13):1598-660 (2007) PMID 17569677
  9. ↑ Recurrent angina after coronary revascularization: a clinical challenge. Eur Heart J 28(9):1057-65 (2007) PMID 17384090
  10. ↑ Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J 28(7):788-97 (2007) PMID 17347176
  11. ↑ The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J 28(4):433-42 (2007) PMID 17267457
  12. ↑ Importance of collateral circulation in coronary heart disease. Eur Heart J 28(3):278-91 (2007) PMID 17218452
  13. ↑ Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? Eur Heart J 27(23):2737-9 (2006) PMID 17107977
  14. ↑ Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J 27(23):2815-22 (2006) PMID 17107976
  15. ↑ Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27(23):2784-814 (2006) PMID 17020889
  16. ↑ A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27(22):2667-74 (2006) PMID 17053008
  17. ↑ Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27(11):1341-81 (2006) PMID 16735367
  18. ↑ Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27(7):779-88 (2006) PMID 16513663
  19. ↑ Long-term anticoagulant therapy in patients with coronary artery disease. Eur Heart J 27(8):913-9 (2006) PMID 16401675
  20. ↑ Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J 26(19):2063-74 (2005) PMID 16055497
  21. ↑ Timing of arrhythmic death after myocardial infarction: does it affect timing of ICD implantation? Eur Heart J 26(14):1350-2 (2005) PMID 15872027
  22. ↑ The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 26(10):1011-22 (2005) PMID 15716284
  23. ↑ Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J 26(9):881-9 (2005) PMID 15681573
  24. ↑ Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 26(8):762-9 (2005) PMID 15778204
  25. ↑ Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26(8):804-47 (2005) PMID 15769784
  26. ↑ Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefit. Eur Heart J 25(19):1667-9 (2004) PMID 15451141
  27. ↑ Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 25(11):902-19 (2004) PMID 15172462
  28. ↑ Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J 25(11):895-7 (2004) PMID 15172459
  29. ↑ Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques. Eur Heart J 24(3):266-73 (2003) PMID 12590904
  30. ↑ A meta-analytical approach for the treatment of in-stent restenosis. Eur Heart J 24(3):217-8 (2003) PMID 12590898
  31. ↑ The challenge of in-stent restenosis: insights from intravascular ultrasound. Eur Heart J 24(2):138-50 (2003) PMID 12573271
  32. ↑ Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24(1):28-66 (2003) PMID 12559937
  33. ↑ Residual myocardial ischaemia as a contributor to electrical instability after myocardial infarction. Eur Heart J 22(20):1845-6 (2001) PMID 11601832
  34. ↑ Multivessel coronary artery disease: current revascularization strategies. Eur Heart J 22(14):1183-97 (2001) PMID 11440491
  35. ↑ The Q wave infarct; phenomenon or chimera? Eur Heart J 22(12):980-2 (2001) PMID 11428830
  36. ↑ Intracoronary radiation therapy. Eur Heart J 22(8):629-47 (2001) PMID 11286520
  37. ↑ The management of refractory angina. Eur Heart J 21(23):1909-10 (2000) PMID 11071793
  38. ↑ Coronary in-stent restenosis - predictors, treatment and prevention. Eur Heart J 21(21):1739-49 (2000) PMID 11052838
  39. ↑ Rotational atherectomy revisited in the era of stenting. Eur Heart J 21(21):1727-9 (2000) PMID 11052832
  40. ↑ Basic aspects of plaque vulnerability. Heart 89(10):1262-7 (2003) PMID 12975444
  41. ↑ Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 89(7):767-72 (2003) PMID 12807853
  42. ↑ Role of echocardiography in acute coronary syndromes. Heart 88(4):419-25 (2002) PMID 12231611
  43. ↑ Angiographic assessment of myocardial perfusion: TIMI myocardial perfusion (TMP) grading system. Heart 86(5):485-6 (2001) PMID 11602533
  44. ↑ The patient with acute myocardial infarction who does not receive reperfusion treatment. Heart 86(3):243-5 (2001) PMID 11514468
  45. ↑ The natural history of acute myocardial infarction. Heart 83(6):726-30 (2000) PMID 10814643
  46. ↑ The pathophysiology of acute coronary syndromes. Heart 83(3):361-6 (2000) PMID 10677422
  47. ↑ Percutaneous myocardial laser revascularisation. Heart 83(3):253-4 (2000) PMID 10677396
  48. ↑ Neurostimulation treatment for angina pectoris. Heart 83(2):217-20 (2000) PMID 10648501
  49. ↑ The radial approach for coronary angiography and stenting. Heart 82(4):411-2 (1999) PMID 10490550
  50. ↑ The radial artery as a conduit for coronary artery bypass grafting. Heart 82(4):409-10 (1999) PMID 10490549
  51. ↑ Pathogenic mechanisms in unstable angina. Heart 82 Suppl 1():I2-4 (1999) PMID 10469669
  52. ↑ Neuroendocrine activation after myocardial infarction: causes and consequences. Heart 76(3 Suppl 3):53-9 (1996) PMID 8977365
  53. ↑ Transmyocardial revascularisation. Heart 76(3):191-2 (1996) PMID 8868972
  54. ↑ Intravascular radiation for restenosis prevention: could it be the holy grail? Heart 76(2):99-100 (1996) PMID 8795465
  55. ↑ Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning. Am J Physiol Heart Circ Physiol 291(6):H2570-82 (2006) PMID 16861690
  56. ↑ Myocardial hibernation: a delicate balance. Am J Physiol Heart Circ Physiol 288(3):H984-99 (2005) PMID 15563526
  57. ↑ Reperfusion arrhythmias and sudden cardiac death: a century of progress toward an understanding of the mechanisms. Circ Res 89(9):741-3 (2001) PMID 11679400
  58. ↑ Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ Res 48(6 Pt 1):767-76 (1981) PMID 7014018
  59. ↑ Autonomic neural influences on the dysrhythmias resulting from myocardial infarction. Circ Res 43(1):1-9 (1978) PMID 350450
  60. ↑ Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction. Circ Res 42(6):740-9 (1978) PMID 350449
  61. ↑ ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116(7):e148-304 (2007) PMID 17679616
  62. ↑ Dynamic left ventricular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence. Circulation 116(5):e110-3 (2007) PMID 17664378
  63. ↑ Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 116(3):316-28 (2007) PMID 17638940
  64. ↑ ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures). Circulation 116(1):98-124 (2007) PMID 17592076
  65. ↑ Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 115(18):e436-9 (2007) PMID 17485582
  66. ↑ Pathological changes in the coronary arteries in the acute coronary syndromes. Heart 92(11):1557-8 (2006) PMID 17041107
  67. ↑ Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies. Heart 92(11):1588-94 (2006) PMID 16740920
  68. ↑ Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry. Heart 92(11):1571-6 (2006) PMID 16644860
  69. ↑ The pathology of myocardial infarction in the pre- and post-interventional era. Heart 92(11):1552-6 (2006) PMID 16621872
  70. ↑ The pathophysiology of myocardial reperfusion: a pathologist's perspective. Heart 92(11):1559-62 (2006) PMID 16547203
  71. ↑ Aspiration thrombectomy and primary percutaneous coronary intervention. Heart 92(7):867-9 (2006) PMID 16670099
  72. ↑ The future of drug eluting stents. Heart 92(5):585-8 (2006) PMID 16216857
  73. ↑ Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92(5):641-9 (2006) PMID 16216853
  74. ↑ Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond. Heart 91(9):1135-40 (2005) PMID 16103539
  75. ↑ The ECG in acute coronary syndromes: new tricks from an old dog. Heart 91(7):851-3 (2005) PMID 15958340
  76. ↑ Pathologic assessment of the vulnerable human coronary plaque. Heart 90(12):1385-91 (2004) PMID 15547008
  77. ↑ Renal dysfunction and acceleration of coronary disease. Heart 90(8):961-6 (2004) PMID 15253986
  78. ↑ Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart 90(7):732-8 (2004) PMID 15201238
  79. ↑ Percutaneous coronary intervention for bifurcation coronary disease. Heart 90(6):713-22 (2004) PMID 15145893
  80. ↑ The pathophysiology of myocardial ischaemia. Heart 90(5):576-80 (2004) PMID 15084567
  81. ↑ Chronic therapeutically refractory angina pectoris. Heart 90(2):225-30 (2004) PMID 14729809
  82. ↑ Clinical implications of the new definition of myocardial infarction. Heart 90(1):99-106 (2004) PMID 14676259
  83. ↑ Plaque stabilisation in acute coronary syndromes: clinical considerations. Heart 89(10):1268-72 (2003) PMID 12975445
  84. ↑ Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 64(1):1-12 (2000) PMID 10651199
  85. ↑ Irradiation and postangioplasty restenosis: a recent overview. Jpn Heart J 41(5):541-70 (2000) PMID 11132163
  86. ↑ Successful use of sirolimus-eluting stents for treatment of ST-elevation acute myocardial infarction caused by left main coronary artery occlusion. Tex Heart Inst J 32(3):421-3 (2005) PMID 16392234
  87. ↑ Transmyocardial laser revascularization. Does it have a role in the treatment of ischemic heart disease? Tex Heart Inst J 25(1):24-9 (1998) PMID 9566059
  88. ↑ Coronary thrombolysis with tissue-type plasminogen activator: prospective review. Tex Heart Inst J 11(4):344-7 (1984) PMID 15226873

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=Koronare_Herzkrankheit_(allg._Teil_4)&oldid=41314“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway